Harvey Capital Management Inc Pfizer Inc Transaction History

Harvey Capital Management Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$25.26 - $29.6 $145,245 - $170,200	-5,750 Reduced 16.64%	28,800 $805,000
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $139,806 - $160,542	-5,400 Reduced 13.52%	34,550 $958,000
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $656,124 - $852,233	-25,110 Reduced 38.6%	39,950 $1.15 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $77,016 - $90,024	-2,400 Reduced 3.56%	65,060 $2.16 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $1.87 Million - $2.16 Million	51,660 Added 326.96%	67,460 $2.47 Million
Q1 2023 May 17, 2023	BUY	$39.39 - $51.28 $346,632 - $451,264	8,800 Added 125.71%	15,800 $644,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $82,640 - $122,500	2,000 Added 40.0%	7,000 $413,000
Q3 2021 Oct 25, 2021	BUY	$39.25 - $50.42 $196,250 - $252,100	5,000 New	5,000 $215,000
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $267,760 - $340,480	-8,000 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$31.75 - $37.25 $254,000 - $298,000	8,000 New	8,000 $293,000
Q3 2019 Oct 17, 2019	SELL	$32.49 - $42.13 $162,450 - $210,650	-5,000 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $38,470 - $43,860	-1,000 Reduced 16.67%	5,000 $218,000
Q3 2018 Oct 24, 2018	SELL	$34.47 - $41.81 $413,640 - $501,720	-12,000 Reduced 66.67%	6,000 $264,000
Q1 2018 Apr 27, 2018	SELL	$31.91 - $37.02 $9,573 - $11,106	-300 Reduced 1.64%	18,000 $638,000
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $8,315 - $8,822	-250 Reduced 1.35%	18,300 $662,000
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $575,050 - $633,482	18,550	18,550 $662,000

3,257

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Harvey Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Harvey Capital Management Inc with notifications on news.